Roche executive O'Day to become new Gilead Sciences CEO

Note: This section contains information in English only.
Source: Dukascopy Bank SA
The drugmaker Gilead Sciences is set to appoint Daniel O'Day, the executive of Roche Holding AG, as the company's new CEO with the official announcement expected to be made on Monday.
Back to articles

Actual Topics

Mon, 10 Dec 2018 05:38:21 GMT

Washington sets March 1 as deadline for trade deal with Beijing

On Sunday, Robert Lighthizer, the US Trade Representative, stated that March 1 was set as the "hard deadline" for reaching an agreement in the US-China trade negotiations.

Mon, 10 Dec 2018 04:27:29 GMT

Egypt approves BP purchase of 25 percent of Nour gas concession

BP and UAE-based Mubadala Investment are set to purchase stakes in the Nour deepwater gas concession of the northern coast of Sinai after approval by the Egyptian Petroleum Ministry.

Subscribe to "Fundamental Analysis" feed

Subscribe
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request)
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Per scoprire di più sulla piattaforma di Dukascopy Bank per Forex/CFD, sul SWFX ed altre informazioni relative al trading,
la preghiamo di contattarci o richiedere di essere contattato (callback request).
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.